- Filed
- Feb 19, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 18, 2025 | 14.27M sh |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $8.17M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $244.8K |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.58M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $705.86K |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.59M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $741.23K |
| Current Assets | Q3 2025 · Dec 31, 2024 | $71.67K |
| Current Assets | Q3 2025 · Mar 31, 2024 | $81.82K |
| Total Assets | Q3 2025 · Dec 31, 2024 | $15.69M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $986.03K |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $13.58K |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $13.58K |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $600 |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $2.4K |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $47.36K |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $47.36K |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $400 |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $1.6K |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 12.04M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 11.82M sh |
| Capex | Q3 2025 · Dec 31, 2023 | $333.25K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$948.13K |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.04 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.10 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.04 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.10 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $399.79K |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $1.06M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$466.19K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$1.2M |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$468.35K |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$1.22M |
| Revenue | Q3 2025 · Dec 31, 2023 | $1K |
| Revenue | Q3 2025 · Dec 31, 2023 | $4K |